Cargando…
Development of Antimetastatic Drugs by Targeting Tumor Sialic Acids
One-third of all cancer categories in clinics have a high incidence of neoplasm metastasis. Neoplasm metastasis is one of the leading causes of cancer deaths. However, the prevailing therapeutic approach to this pathogenic process is presently unsatisfactory. Paradoxically to our efforts and expecta...
Autores principales: | Lu, Da-Yong, Lu, Ting-Ren, Wu, Hong-Ying |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Österreichische Apotheker-Verlagsgesellschaft
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3447616/ https://www.ncbi.nlm.nih.gov/pubmed/23008802 http://dx.doi.org/10.3797/scipharm.1205-01 |
Ejemplares similares
-
Inhibitions of Several Antineoplastic Drugs on Serum Sialic Acid Levels in Mice Bearing Tumors
por: Lu, Da-Yong, et al.
Publicado: (2013) -
Sialic Acid-Targeted Biointerface Materials and Bio-Applications
por: Xiong, Yuting, et al.
Publicado: (2017) -
Experimental Evidence of the Antitumor, Antimetastatic and Antiangiogenic Activity of Ellagic Acid
por: Ceci, Claudia, et al.
Publicado: (2018) -
Enhanced Melanoma‐Targeted Therapy by “Fru‐Blocked” Phenyboronic Acid‐Modified Multiphase Antimetastatic Micellar Nanoparticles
por: Long, Yang, et al.
Publicado: (2018) -
Development of miracle medicines from sialic acids
por: OGURA, Haruo
Publicado: (2011)